Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Hesseling

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 17, 2010
Mycobacterial genotype is associated with disease phenotype in childrenA C Hesseling, B J Marais, H L Kirchner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 13, 2012
High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trialA C Hesseling, S Kim, S Madhi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 29, 2008
High level of discordant IGRA results in HIV-infected adults and childrenA M Mandalakas, A C Hesseling, N N Chegou, et al.
Thorax|August 7, 2008
Highly discordant T cell responses in individuals with recent exposure to household tuberculosisA C Hesseling, A M Mandalakas, H L Kirchner, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2016
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment GuidelinesA Bekker, H S Schaaf, H R Draper, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention studyE R Maritz, G Montepiedra, L Liu, et al.
IJTLD Open|March 17, 2025
Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatmentS E Purchase, J Brigden, J A Seddon, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2009
Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosisH S Schaaf, T C Victor, A Venter, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendationsS Thee, J A Seddon, P R Donald, et al.
Public Health Action|December 23, 2022
Caregivers' perspectives on health-related quality of life in young children with TB and respiratory illnessesM G Anthony, G Hoddinott, M Van Niekerk, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 17, 2010
Mycobacterial genotype is associated with disease phenotype in childrenA C Hesseling, B J Marais, H L Kirchner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 13, 2012
High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trialA C Hesseling, S Kim, S Madhi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 29, 2008
High level of discordant IGRA results in HIV-infected adults and childrenA M Mandalakas, A C Hesseling, N N Chegou, et al.
Thorax|August 7, 2008
Highly discordant T cell responses in individuals with recent exposure to household tuberculosisA C Hesseling, A M Mandalakas, H L Kirchner, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2016
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment GuidelinesA Bekker, H S Schaaf, H R Draper, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention studyE R Maritz, G Montepiedra, L Liu, et al.
IJTLD Open|March 17, 2025
Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatmentS E Purchase, J Brigden, J A Seddon, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2009
Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosisH S Schaaf, T C Victor, A Venter, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendationsS Thee, J A Seddon, P R Donald, et al.
Public Health Action|December 23, 2022
Caregivers' perspectives on health-related quality of life in young children with TB and respiratory illnessesM G Anthony, G Hoddinott, M Van Niekerk, et al.
Pageof 12